Site search
2923 results for '' found
LOTUS - Low dose combinations to improve stroke outcomes (ACTRN12624001279516)
LOTUS - Low dose combinations to improve stroke outcomes (ACTRN12624001279516)
/
Screening for cardiac amyloidosis in patients with new conduction disease at the Alfred (ACTRN12624000520538)
Screening for cardiac amyloidosis in patients with new conduction disease at the Alfred (ACTRN12624000520538)
/
Moderately accelerated pacing in patients with cardiac amyloidosis (ACTRN12625000386437)
Moderately accelerated pacing in patients with cardiac amyloidosis (ACTRN12625000386437)
/
A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients with Newly Diagnosed FLT3-ITD + Acute M
A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients with Newly Diagnosed FLT3-ITD + Acute M
/
Alfred Mental & Addiction Health Cultural Safety, Equity and Access Strategic Direction 2026-2028 pdf
AMAH_CSEA_Strategy_Direction_2026-2028_Digital.pdf
Transition_Care_Program_Guide.pdf
Transition_Care_Program_Client_Service_Agreement.pdf
Wellness_Centre_Newsletter_May_2026.pdf
https://www.clinicaltrialsandresearch.vic.gov.au/ethics-application
https://app.prompt.org.au/download/262643?code=221a80cb-7815-492b-abd8-fe954d16edd6